Narrow-moat Sonic’s top line continues to grow at a steady clip, with organic revenue up 6% so far in the second half of fiscal 2024, following 6% growth in the first half. Our fiscal 2024 revenue forecast of AUD 8.9 billion is broadly unchanged and in line with company guidance.
Sonic has a leading market position in most of its geographies and as a result benefits from a cost advantage derived from scale.
Elevated covid-19 testing is not able to be maintained and acquisitive growth is becoming more expensive to achieve.
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.69 | 2.56 | 16.08 |
Price/Book Value | 1.51 | 0.90 | 2.42 |
Price/Sales | 1.39 | 0.46 | 1.70 |
Price/Cash Flow | 10.19 | 2.77 | 11.19 |
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Quick Ratio | 0.78 | 0.44 | 0.78 |
Current Ratio | 0.94 | 0.53 | 0.97 |
Interest Coverage | 5.95 | −13.26 | 7.31 |
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.07% | 0.10% | 7.33% |
Return on Equity (Normalized) | 7.01% | 0.23% | 15.76% |
Return on Invested Capital (Normalized) | 4.52% | 2.27% | 9.73% |
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Hsttqlnrct | Zzrr | $222.9 Bil | |
DHR
| Danaher Corp | Xfwfwhpg | Sqhfpxh | $194.6 Bil | |
A
| Agilent Technologies Inc | Xhhkqvvfw | Zpbp | $44.2 Bil | |
IDXX
| IDEXX Laboratories Inc | Lnxncfcr | Tqwfhh | $42.7 Bil | |
IQV
| IQVIA Holdings Inc | Pxgldqch | Qxgqgr | $41.8 Bil | |
MTD
| Mettler-Toledo International Inc | Sszyfbxjkw | Pcchs | $31.6 Bil | |
ICLR
| Icon PLC | Jfywzrrp | Tcwqlc | $26.5 Bil | |
WAT
| Waters Corp | Brdwqrcpv | Pwhds | $20.0 Bil | |
ILMN
| Illumina Inc | Fppgwjpv | Nmsvsp | $17.0 Bil | |
LH
| Labcorp Holdings Inc | Xlvgcbxr | Thyxqr | $16.8 Bil |
